15% OFF $150+· CodeFALL15
Ends October 15Shop now
Lot certificates published
Discreet shipping

Compound monograph

Examorelin (Hexarelin)

Examorelin, widely supplied as hexarelin, is a synthetic hexapeptide growth hormone secretagogue carrying a 2-methylated D-tryptophan.

Published: 2026-09-13Literature/identifier verification: 2026-09-13
HexarelinEP-23905MF-6003Growth hormone secretagogues

01

Identity & nomenclature

Examorelin, widely supplied as hexarelin, is a synthetic hexapeptide growth hormone secretagogue carrying a 2-methylated D-tryptophan.

Examorelin and hexarelin are one substance under two names, not two entries. Its relationship to GHRP-6 is a single methyl group — a net CH2, 14.0157 Da — but 'methylated GHRP-6' is insufficient identity information unless the methyl position is retained.

Declared aliases and development codes: Hexarelin, EP-23905, MF-6003.

02

Molecular properties

Molecular formulaC47H58N12O6
Molecular mass887.06 Da
CAS Registry Number140703-51-1
PubChem CID6918297
UNII09QF37C617
Three-letter sequenceHis–2-Me-D-Trp–Ala–Trp–D-Phe–Lys–NH2

Position 2 carries a methyl group at INDOLE POSITION 2 of D-tryptophan. It is not an N-methyl and not an alpha-methyl substitution; those are different molecules with the same formula. No one-letter string is published here.

03

Structural characteristics

This is the compound that refutes the assumption that synthetic secretagogues are interchangeable or GHSR-exclusive. Beyond ghrelin-receptor agonism, exact-compound work identifies CD36 as a binding target, maps the binding site to a defined fragment of the CD36 sequence, and reports that a cardiovascular response to hexarelin is absent in CD36-null animals. CD36 is a scavenger receptor, not a GHSR subtype. The relative contribution of the two targets belongs to the preparation tested, not to the compound in general.

  • 2-methyl-D-tryptophan at position 2
  • D-Phe5

Terminal features: Free N-terminus, C-terminal amide at Lys6.

04

Molecular targets & mechanisms

05

Analytical considerations

The mass difference from GHRP-6 is readily measurable, but equal-mass methyl positional isomers and D/L variants are not resolved by mass alone; establishing the indole-2 position needs NMR or an authenticated orthogonal comparison. A positive GHSR assay is unusually weak evidence here, because the compounds it would distinguish this from were selected for sharing that activity.

06

Verified bibliography

  1. CD36 mediates the cardiovascular action of growth hormone-releasing peptides in the heart.

    Bodart V, Febbraio M, Demers A, McNicoll N, Pohankova P, Perreault A, Sejlitz T, Escher E, Silverstein RL, Lamontagne D, Ong H

    Circulation research · 2002-05-03 · Journal Article

    current
  2. Identification of the growth hormone-releasing peptide binding site in CD36: a photoaffinity cross-linking study.

    Demers A, McNicoll N, Febbraio M, Servant M, Marleau S, Silverstein R, Ong H

    The Biochemical journal · 2004-09-01 · Journal Article

    current
  3. Determination of growth hormone releasing peptides (GHRP) and their major metabolites in human urine for doping controls by means of liquid chromatography mass spectrometry.

    Thomas A, Höppner S, Geyer H, Schänzer W, Petrou M, Kwiatkowska D, Pokrywka A, Thevis M

    Analytical and bioanalytical chemistry · 2011-02-06 · Journal Article

    current

10

Methodology & citation verification

Reference identity is checked against official PubMed metadata. Local deterministic receipts bind each normalized title and canonical metadata record to its verification date. Scientific values remain absent when an authoritative source has not been verified.

Read the full methodology →